The Influence of SARS-CoV-2 on Minimally Invasive Therapeutic Approach for Benign Prostatic Hyperplasia

S Balacescu1, R Popescu1,2, D Georgescu1,2

  • 1Department of Urology, "Sf. Ioan" Clinical Hospital of Emergency, Bucharest, Romania.

Maedica
|February 23, 2023
PubMed
Summary

The COVID-19 pandemic impacted benign prostatic hyperplasia (BPH) patient management, with most cases delaying chronic BPH treatment until viral remission. SARS-CoV-2 did not clearly influence BPH patient outcomes.